Filter News
Area of Research
- (-) Biological Systems (1)
- (-) Isotopes (5)
- (-) Nuclear Science and Technology (1)
- Biology and Environment (48)
- Biology and Soft Matter (1)
- Clean Energy (28)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (1)
- Fusion and Fission (2)
- Materials (24)
- Materials for Computing (6)
- National Security (8)
- Neutron Science (12)
- Supercomputing (49)
News Topics
- (-) Biomedical (6)
- (-) Climate Change (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (6)
- Bioenergy (2)
- Computer Science (3)
- Coronavirus (1)
- Decarbonization (1)
- Environment (1)
- Fusion (7)
- Isotopes (25)
- Materials (3)
- Materials Science (5)
- Molten Salt (1)
- National Security (1)
- Neutron Science (2)
- Nuclear Energy (26)
- Physics (2)
- Security (1)
- Space Exploration (6)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
Three scientists from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Association for the Advancement of Science, or AAAS.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
While studying the genes in poplar trees that control callus formation, scientists at Oak Ridge National Laboratory have uncovered genetic networks at the root of tumor formation in several human cancers.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.